NO20003515L - FremgangsmÕte for identifisering av validerte mÕl- og analysekombinasjoner - Google Patents

FremgangsmÕte for identifisering av validerte mÕl- og analysekombinasjoner

Info

Publication number
NO20003515L
NO20003515L NO20003515A NO20003515A NO20003515L NO 20003515 L NO20003515 L NO 20003515L NO 20003515 A NO20003515 A NO 20003515A NO 20003515 A NO20003515 A NO 20003515A NO 20003515 L NO20003515 L NO 20003515L
Authority
NO
Norway
Prior art keywords
procedure
validated measurement
analysis combinations
identifying validated
identifying
Prior art date
Application number
NO20003515A
Other languages
English (en)
Other versions
NO20003515D0 (no
Inventor
Francis P Tally
Jianshi Tao
Philip A Wendler
Gene Connely
Paul L Gallant
Original Assignee
Cubist Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cubist Pharm Inc filed Critical Cubist Pharm Inc
Publication of NO20003515D0 publication Critical patent/NO20003515D0/no
Publication of NO20003515L publication Critical patent/NO20003515L/no

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/03Animal model, e.g. for test or diseases
    • A01K2267/0337Animal models for infectious diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO20003515A 1998-01-09 2000-07-07 FremgangsmÕte for identifisering av validerte mÕl- og analysekombinasjoner NO20003515L (no)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US7096598P 1998-01-09 1998-01-09
US7663898P 1998-03-03 1998-03-03
US8175398P 1998-04-14 1998-04-14
US8584498P 1998-05-18 1998-05-18
US8982898P 1998-06-19 1998-06-19
US9469898P 1998-07-30 1998-07-30
US10021198P 1998-09-14 1998-09-14
US10171898P 1998-09-24 1998-09-24
US10775198P 1998-11-10 1998-11-10
PCT/US1999/000474 WO1999035494A1 (en) 1998-01-09 1999-01-08 Method for identifying validated target and assay combinations

Publications (2)

Publication Number Publication Date
NO20003515D0 NO20003515D0 (no) 2000-07-07
NO20003515L true NO20003515L (no) 2000-09-07

Family

ID=27578329

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003515A NO20003515L (no) 1998-01-09 2000-07-07 FremgangsmÕte for identifisering av validerte mÕl- og analysekombinasjoner

Country Status (5)

Country Link
EP (1) EP1046034A1 (no)
AU (1) AU2218199A (no)
CA (1) CA2317653A1 (no)
NO (1) NO20003515L (no)
WO (1) WO1999035494A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6139817A (en) * 1996-10-15 2000-10-31 Smithkline Beecham Corporation Method for determining gene essentiality in a pathogen
US6228579B1 (en) 1997-11-14 2001-05-08 San Diego State University Foundation Method for identifying microbial proliferation genes
US20030190740A1 (en) 1998-10-13 2003-10-09 The University Of Georgia Research Foundation, Inc Stabilized bioactive peptides and methods of identification, synthesis, and use
MXPA01003770A (es) 1998-10-13 2002-05-06 Univ Georgia Res Found Peptidos bioactivos estabilizados, y metodos de identificacion, sintesis y uso de los mismos.
US6599692B1 (en) 1999-09-14 2003-07-29 Sangamo Bioscience, Inc. Functional genomics using zinc finger proteins
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6780590B2 (en) 1999-09-14 2004-08-24 Sangamo Biosciences, Inc. Gene identification
WO2001034810A2 (en) 1999-11-09 2001-05-17 Elitra Pharmaceuticals, Inc. Genes essential for microbial proliferation
IL150069A0 (en) 1999-12-06 2002-12-01 Sangamo Biosciences Inc Methods of using randomized libraries of zinc finger proteins for the identification of gene function
WO2002016940A2 (en) * 2000-08-23 2002-02-28 Genome Therapeutics Corporation Genomics-assisted rapid identification of targets
CH698246B1 (de) * 2001-12-20 2009-06-30 Hoffmann La Roche Test zur Identifizierung von Inhibitoren von Beta-Sekretasen.
WO2011083147A1 (en) 2010-01-08 2011-07-14 Cemm-Forschungsinstitut Für Molekulare Medizin Gmbh Wave1 inhibition in the medical intervention of inflammatory diseases and/or infections caused by a pathogen
WO2011131626A1 (en) 2010-04-19 2011-10-27 Medizinische Universität Innsbruck Tmem195 encodes for tetrahydrobiopterin-dependent alkylglycerol monooxygenase activity
AU2013307383A1 (en) 2012-08-27 2015-03-26 Cemm - Forschungszentrum Fur Molekulare Medizin Gmbh Aminoheteroaryl compounds as MTH1 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079143A (en) * 1990-05-02 1992-01-07 The Upjohn Company Method of indentifying compounds useful as antiparasitic drugs
GB9514184D0 (en) * 1995-07-12 1995-09-13 Zeneca Ltd Assay

Also Published As

Publication number Publication date
EP1046034A1 (en) 2000-10-25
WO1999035494A1 (en) 1999-07-15
CA2317653A1 (en) 1999-07-15
NO20003515D0 (no) 2000-07-07
AU2218199A (en) 1999-07-26

Similar Documents

Publication Publication Date Title
DE69834754D1 (de) Probenanalysesystem
NO984355D0 (no) FremgangsmÕte for mÕling av en analytts konsentrasjon
DE69726576D1 (de) Probe zur Ortsmarkierung
DE69715255D1 (de) Verteilte überwachungs-/mess-anordnung zur gesundheitsversorgung
DE69934091D1 (de) Test zur bestimmung von kraftdiskriminierung
NO963175D0 (no) Analyse- og målemetode
DE69515643D1 (de) Fühlerprobe
FI981133A0 (fi) Mittausmenetelmä ja -järjestelmä
DE69916716D1 (de) Polarimeter und zugehöriges messverfahren
DE69617148D1 (de) Fühlerprobe
NO20003515D0 (no) FremgangsmÕte for identifisering av validerte mÕl- og analysekombinasjoner
DE69819008D1 (de) Mikroskop zur nachgiebigkeitsmessung
DE59713051D1 (de) Probe
DE69930185D1 (de) Abtastende Fluoreszenznachweisvorrichtung
DE69832765D1 (de) Mikrowellenkonzentrationsmessvorrichtung
DE69941322D1 (de) Verbindungstestverfahren
DE69902955D1 (de) Microtome
ID28840A (id) Pengujian
FI981029A0 (fi) Menetelmä ja järjestely testaukseen
FI981431A (fi) Mittausmenetelmä
NO982074D0 (no) FremgangsmÕte og instrument for nivÕmÕling
DE69618904D1 (de) Probenanalyse
DE19880533T1 (de) Spektralanalyse
FI981990A0 (fi) Mittausmenetelmä ja mittauslaite
FI3447U1 (fi) Näytteenlämmitin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application